Literature DB >> 7400692

Characterization of apolipoprotein E-rich high density lipoproteins in familial lecithin:cholesterol acyltransferase deficiency.

C D Mitchell, W C King, K R Applegate, T Forte, J A Glomset, K R Norum, E Gjone.   

Abstract

We have isolated and charachterized a subfraction of high density lipoproteins, rich in apolipoprotein E, from the plasma of patients afflicted with familial lecithin:cholesterol acyltransferase deficiency. Prepared by successive ultracentrifugal flotation, affinity chromatography on heparin-agarose, and affinity chromatography on conconavalin A-agarose, the subfraction contained disc-shaped lipoproteins that measured 14--40 nm in diameter and 4.4--4.5 nm in thickness. The major components were apolipoprotein E, phosphatidylcholine, and unesterified cholesterol, though other apolipoproteins and lipids were present in small amounts. A second subfraction of high density lipoproteins, isolated during the chromatography, contained apolipoproteins A-I and A-II, but no apolipoprotein E. This subfraction included disc-shaped lipoproteins, 13--24 nm in diameter, as well as small round particles, 5.7 nm in diameter. Both subfractions contained similar proportions of total protein relative to lipid, similar amounts of unesterified cholesterol relative to phosphatidylcholine, and a similar distribution of phosphatidylcholine fatty acid.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400692

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  14 in total

1.  Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.

Authors:  Kyriakos E Kypreos; Vassilis I Zannis
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

2.  Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells.

Authors:  J F Oram; E A Brinton; E L Bierman
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

3.  Specific high-affinity binding of high density lipoproteins to cultured human skin fibroblasts and arterial smooth muscle cells.

Authors:  R Biesbroeck; J F Oram; J J Albers; E L Bierman
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

Review 4.  Apolipoprotein E.

Authors:  V I Zannis; J L Breslow
Journal:  Mol Cell Biochem       Date:  1982-01-16       Impact factor: 3.396

Review 5.  Why targeting HDL should work as a therapeutic tool, but has not.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

6.  Lecithin:cholesterol acyltransferase-mediated modification of discoidal peripheral lymph high density lipoproteins: possible mechanism of formation of cholesterol-induced high density lipoproteins (HDLc) in cholesterol-fed dogs.

Authors:  L Dory; C H Sloop; L M Boquet; R L Hamilton; P S Roheim
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

Review 7.  High density lipoprotein biogenesis, cholesterol efflux, and immune cell function.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11       Impact factor: 8.311

8.  Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins.

Authors:  M E Haberland; A M Fogelman; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

9.  Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferase.

Authors:  L Wong; L K Curtiss; J Huang; C J Mann; B Maldonado; P S Roheim
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

10.  Characterization and purification of polydisperse reconstituted lipoproteins and nanolipoprotein particles.

Authors:  Craig D Blanchette; Brent W Segelke; Nicholas Fischer; Michele H Corzett; Edward A Kuhn; Jenny A Cappuccio; William Henry Benner; Matthew A Coleman; Brett A Chromy; Graham Bench; Paul D Hoeprich; Todd A Sulchek
Journal:  Int J Mol Sci       Date:  2009-07-02       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.